Test Price
2,800 AED✅ Home Collection Available
MYH3 Gene Distal Arthrogryposis Type 2A Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين MYH3 للاعوجاج المفصلي البعيد من النوع 2A في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي 2026
Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: Paid Hospital‑Grade Home Collection via ISO Certified Cold‑Chain Home Collection and VIP Mobile Phlebotomy.
- Clinical Guidance: Telephonic Post‑Test Clinical Guidance in result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
يضمن اختبار الجين MYH3 بتقنية التسلسل الجيني (NGS) حساسية تشخيصية بنسبة 99.9% مع خدمة السحب المنزلي المعتمدة والمشورة الوراثية بعد الفحص. تتوافق جميع الإجراءات مع القانون الاتحادي رقم 41 لسنة 2024 (المادة 87) وقانون CDS 2026 لحماية القصّر وقانون حماية البيانات الشخصية في الإمارات.
Clinical Overview
This advanced NGS test sequences the entire coding region of the MYH3 gene to diagnose distal arthrogryposis type 2A (DA2A), a congenital contracture syndrome affecting distal joints with characteristic facial features. In the UAE, this 2,800 AED examination is the definitive molecular diagnostic tool for confirming genetic etiology and guiding multidisciplinary management.
يُعدّ هذا التحليل الجزيئي المعيار الذهبي لتأكيد تشخيص الاعوجاج المفصلي البعيد من النوع 2A وتوجيه الخطة العلاجية متعددة التخصصات في دولة الإمارات.
| Feature | Our NGS Test (MYH3) | Sanger Sequencing (Alternative) |
|---|---|---|
| Coverage | Full coding region + intron‑exon boundaries | Single exon targeted |
| Variant Detection | SNVs, indels, CNVs with high depth | Only SNVs and small indels |
| Turnaround Time | 3 – 4 Weeks | 4 – 6 Weeks |
| Regulatory Compliance | 2026 DHA‑MOHAP NGS Guidelines | Legacy CLIA (non‑DHA specific) |
Physician Insight & Safety Protocol
“As a clinician, I understand the anxiety that a genetic diagnosis can bring. This NGS test, when interpreted in the context of a complete clinical evaluation, provides a definitive molecular diagnosis for distal arthrogryposis type 2A, enabling targeted care and family planning. Please remember that genetic results should always be correlated with a specialist’s clinical assessment.”
— Dr. PRABHAKAR REDDY, DHA License: 61713011
⚠️ Clinical Notice: Do not discontinue any prescribed medication or alter your treatment plan based solely on genetic test results. Always consult your treating physician.
Exclusion Criteria & Emergency Red Flags
- This test is not indicated for acute medical emergencies or for screening asymptomatic individuals without a clinical suspicion of DA2A.
- If you are pregnant and considering prenatal diagnosis, a separate genetic counselling session is mandatory prior to sample collection.
- ER Red Flags: Seek immediate emergency care if you or your child experience sudden worsening of joint contractures, respiratory distress, or feeding difficulties.
Patient FAQ & Clinical Guidance
1. What is the MYH3 Gene Distal Arthrogryposis Type 2A Genetic Test used for?
This advanced genetic test detects mutations in the MYH3 gene to confirm distal arthrogryposis type 2A, providing essential diagnostic clarity for joint contractures and associated features.
يستخدم هذا الاختبار للكشف عن الطفرات في جين MYH3 لتأكيد تشخيص الاعوجاج المفصلي البعيد من النوع 2A وتوجيه الإدارة السريرية.
2. How is the performed and what sample is required?
Our mobile phlebotomist collects a blood sample, extracted DNA, or a single drop of blood on an FTA card during a convenient home visit across the UAE.
يقوم أخصائي السحب لدينا بجمع عينة دم أو حمض نووي مستخلص أو قطرة دم واحدة على بطاقة FTA خلال زيارة منزلية مريحة.
3. What do the results mean and how long does it take to receive them?
Results are interpreted by a clinical geneticist to confirm diagnosis and guide management; the standard turnaround time is 3 to 4 weeks.
يفسّر استشاري الوراثة النتائج لتأكيد التشخيص وتوجيه العلاج، وتتراوح مدة ظهور النتائج بين 3 و4 أسابيع.
⚕️ DHA‑Licensed Facility (No. 9834453) • ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) • Fully compliant with Federal Decree‑Law No. 41 of 2024, UAE CDS 2026, and UAE Personal Data Protection Law.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians